Genomic regions associated with multiple sclerosis are active in B cells.
More than 50 genomic regions have now been shown to influence the risk of multiple sclerosis (MS). However, the mechanisms of action, and the cell types in which these associated variants act at the molecular level remain largely unknown. This is especially true for associated regions containing no...
Saved in:
Main Authors: | Giulio Disanto, Geir Kjetil Sandve, Antonio J Berlanga-Taylor, Julia M Morahan, Ruth Dobson, Gavin Giovannoni, Sreeram V Ramagopalan |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/541fa2c204794509a8299aba3a99f8e9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroprotection in a novel mouse model of multiple sclerosis.
by: Katie Lidster, et al.
Published: (2013) -
Measuring treatment response to advance precision medicine for multiple sclerosis
by: Peter A. Calabresi, et al.
Published: (2021) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
by: E. P. Evdoshenko, et al.
Published: (2014) -
Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq.
by: Ying Yao, et al.
Published: (2021) -
Pregnancy-induced effects on memory B-cell development in multiple sclerosis
by: Malou Janssen, et al.
Published: (2021)